lobbying_activities: 3424682

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3424682	ce929baf-b017-41ea-b4ef-a41233efc090	Q3	COHERUS BIOSCIENCES, INC.	401103810	COHERUS BIOSCIENCES, INC.	2025	third_quarter	GOV	Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.	Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Defense Advanced Research Projects Agency (DARPA),Defense Nuclear Facilities Safety Board,Energy, Dept of,Executive Office of the President (EOP),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),Office of Management & Budget (OMB),President of the U.S.,SENATE,Vice President of the U.S.,White House Office		125000	0	0	2025-08-18T16:09:32-04:00